APA (7th ed.) Citation

Elkilany, A., Geisel, D., Müller, T., Fischer, A., & Denecke, T. (2021). Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: Added value in assessing liver function and monitoring disease progression. Abdominal Radiology, 46(3), 979. https://doi.org/10.1007/s00261-020-02731-z

Chicago Style (17th ed.) Citation

Elkilany, Aboelyazid, Dominik Geisel, Tobias Müller, Andreas Fischer, and Timm Denecke. "Gadoxetic Acid-enhanced MRI in Primary Sclerosing Cholangitis: Added Value in Assessing Liver Function and Monitoring Disease Progression." Abdominal Radiology 46, no. 3 (2021): 979. https://doi.org/10.1007/s00261-020-02731-z.

MLA (9th ed.) Citation

Elkilany, Aboelyazid, et al. "Gadoxetic Acid-enhanced MRI in Primary Sclerosing Cholangitis: Added Value in Assessing Liver Function and Monitoring Disease Progression." Abdominal Radiology, vol. 46, no. 3, 2021, p. 979, https://doi.org/10.1007/s00261-020-02731-z.